Literature DB >> 32360186

Arterial resections in pancreatic cancer - Systematic review and meta-analysis.

Piotr Małczak1, Marek Sierżęga2, Tomasz Stefura3, Artur Kacprzyk3, Jakub Droś3, Oksana Skomarovska3, Marta Krzysztofik3, Piotr Major4, Michał Pędziwiatr4.   

Abstract

BACKGROUND: The number of pancreatic resections due to cancers is increasing. While concomitant venous resections are routinely performed in specialized centers, arterial resections are still controversial. Nevertheless they are performed in patients presenting with locally advanced tumors. Our aim was to summarize currently available literature comparing peri-operative and long-term outcomes of arterial and non-arterial pancreatic resections.
METHODS: We included studies comparing pancreatic operations with and without concomitant arterial resection. Inclusion criteria were morbidity or mortality. Studies additionally reporting venous resections with no possibility of excluding this data during the extraction were discarded.
RESULTS: The initial search yielded 1651 records. Finally, 19 studies were included in the analysis involving 2710 patients. Arterial resection was associated with a greater risk of death(RR: 4.09; p < 0.001) and complications (RR: 1.4; p = 0.01). There were no differences in the rate of pancreatic fistula, biliary fistula rate, cardiopulmonary complications, length of hospital stay and non-R0 rate. Oncologically, patients after arterial resection were at higher risk of worse 3-year survival.
CONCLUSION: Arterial resection in pancreatic cancer is associated with an increased risk of mortality and complications in comparison to standard non-arterial resections. Nevertheless, arterial resection may become a viable treatment for selected patients in high volume centers.
Copyright © 2020 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32360186     DOI: 10.1016/j.hpb.2020.04.005

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  10 in total

Review 1.  Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling.

Authors:  Thomas J Ettrich; Niklas Sturm; Melanie Güthle; Felix J Hüttner; Lukas Perkhofer
Journal:  Visc Med       Date:  2022-01-19

2.  Synchronous arterial resection in pancreatic cancer: A case report.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihai Dimitriu; Cristian Balalau; Florentina Furtunescu; Florentina Gherghiceanu; Daniel Radavoi; Camelia Diaconu; Ovidiu Stiru; Cornel Savu; Vladislav Brasoveanu; Claudia Stoica; Ioan Cordos
Journal:  Exp Ther Med       Date:  2022-03-15       Impact factor: 2.447

Review 3.  [Surgical treatment of pancreatic cancer-What is new?]

Authors:  Thomas Schmidt; Orlin Belyaev; Waldemar Uhl; Christiane J Bruns
Journal:  Chirurg       Date:  2022-03-31       Impact factor: 0.955

Review 4.  Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status.

Authors:  Anant Ramaswamy; Sujay Srinivas; Vikram Chaudhari; Prabhat Bhargava; Manish Bhandare; Shailesh V Shrikhande; Vikas Ostwal
Journal:  Ecancermedicalscience       Date:  2022-03-24

Review 5.  Distal Pancreatectomy With Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer - A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihai Dimitriu; Cristian Balalau; Florentina Furtunescu; Florentina Gherghiceanu; Daniel Radavoi; Camelia Diaconu; Ovidiu Stiru; Cornel Savu; Vladislav Brasoveanu; Claudia Stoica; Ioan Cordos
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Current Practice.

Authors:  Georgios Gemenetzis; Siobhan McKay; Samir Pathak; John Moir; Richard Laing; Nigel B Jamieson; Alastair L Young; Nikolaos A Chatzizacharias; Francesco Giovinazzo; Keith J Roberts
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

7.  Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma.

Authors:  Yugal Limbu; Sujan Regmee; Roshan Ghimire; Dhiresh Kumar Maharjan; Prabin Bikram Thapa
Journal:  Cureus       Date:  2021-12-08

8.  Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches

Authors:  Seung Eun Lee; Sung-Sik Han; Chang Moo Kang; Wooil Kwon; Kwang Yeol Paik; Ki Byung Song; Jae Do Yang; Jun Chul Chung; Chi-Young Jeong; Sun-Whe Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

Review 9.  Vascular Resection in Pancreatectomy-Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?

Authors:  Beata Jabłońska; Robert Król; Sławomir Mrowiec
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 10.  [Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma].

Authors:  Shin Hye Hwang; Mi-Suk Park
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.